An unconditional approval of Life Healthcare and Joint Medical Holdings has been granted by the Competition Tribunal for the companies who own private South African hospitals. The Competition Commission had previously asked the Tribunal to prohibit the merger, citing competition concerns. The Tribunal’s biggest concern, according to reports, was in regards to whether Joint Medical Holdings’ pricing of medical schemes would increase after the merger, but ultimately found the deal does not pose a threat to competition.
Featured News
Wave of Departures Hits Justice Department’s Antitrust Division
Apr 8, 2026 by
CPI
AI-Powered Shopping by Google Raises New Competition Questions
Apr 8, 2026 by
CPI
SEC Fills Top Enforcement Role Following Resignation
Apr 8, 2026 by
CPI
Anthropic Joins Forces With Amazon, Microsoft, Apple on Cyber Defense AI
Apr 8, 2026 by
CPI
Hungary Competition Official Alleges Political Pressure as Election Nears
Apr 8, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Competitor Collaborations
Mar 26, 2026 by
CPI
Between Scylla and Charybdis – Navigating Transatlantic Antitrust Currents
Mar 26, 2026 by
Tilman Kuhn & Niklas Brüggemann
Cartel Enforcement Moves Into the Labor Market: Trends and Implications
Mar 26, 2026 by
Andreas Kafetzopoulos & Caroline Janssens
Rethinking Buy-Side Antitrust “Group Boycotts”
Mar 26, 2026 by
Craig Falls & Brendan McGuire
Positive Collaborations: The Tools Available to Competition Authorities to Encourage Beneficial Interactions Between Competitors
Mar 26, 2026 by
Rona Bar-Isaac & Thomas Withers